CASMI is one focal point for a networked organisation that is committed to understanding and developing better and more sustainable means of effecting medical innovation.
Who we are
Supported by the NIHR biomedical research centre at UCLH, CASMI recognises the issues that have led to current failures in the translation of basic bioscience into affordable and widely adopted new treatments. It has been our collective ambition to further the development of sustainable medical innovation by fostering collaborative links between academics and professional specialists locally, with our founding partner Oxford, new institutions in the UK and beyond.
There is no doubting the importance of the agenda that CASMI is pursuing, emphasised by the Life Sciences Industrial Strategy and the challenges and opportunities confronting medical innovation in post-Brexit Britain. CASMI represents an opportunity to encourage interdisciplinary and interinstitutional research and scholarship, highlighting and organising relevant meetings and influencing policy and practice. By extending our network we hope to provide a platform for debate which can provide proactive solutions for the challenges currently facing medical innovation.
CASMI activities are overseen by the CASMI Steering Group.
The overarching purpose of the CASMI Steering Group is to devise and oversee the implementation of the strategy for CASMI in pursuit of more efficient and sustainable medical innovation, which adds value to the efforts of other parts of UCL and projects the university and the BRC as key players in advancing this agenda for public good.
- CASMI Steering Group
Professor Sir John Tooke
Dr Nick McNally
Chief Operating Officer, UCL BRC
Dr Karen Groot/David Wiseman
Strategic Coordinator, UCL OVPH
Professor Rob Horne
CASMI Academic Lead, Practice and Policy UCL
Dr Jane Kinghorn
Director Translational Research Office, UCL OVPH
Mrs Michelle Craft
Partnerships and Projects Coordinator, UCL OVPH
- Terms of Reference
1) To devise and oversee the implementation of the strategy for CASMI in pursuit of more efficient and sustainable medical innovation that adds value to the efforts of other parts of UCL and projects the university and the BRC as key players in advancing this agenda for public good.
2) To foster collaborative links locally, with our previous partner Oxford, and new institutions in the UK and beyond.
3) To sustain and build the CASMI Fellowship to create an increasing network of academics and professionals committed to the CASMI agenda.
4) To foster close links with the Academy of Medical Sciences FORUM programme.
5) To support the agendas of the BRC, TRO, and Institute for Personalised Medicine and take forward research and policy influencing opportunities revealed by their activities.
6) To oversee a communication plan that that supports the activities above, including development and maintenance of the new website.
7) To seek to develop meetings to foster the community committed to the CASMI agenda.
8) To build and oversee the financial support from sponsorship or funding contributions via external parties/partners and make the collaboration independent of UCL/BRC funding.